Charcoal haemoperfusion was successful in the treatment of severe butobarbitone poisoning complicated by resistant hypotension. At the same time the rapid removal of paracetamol may have lessened the severity of the subsequent hepatic injury. The mechanism and management of shock associated with barbiturate poisoning, and the possible application of haemoperfusion in paracetamol poisoning are discussed.
Introduction
Charcoal haemoperfusion is an effective method of removing various poisons from the blood (Volans et al., 1977; Hampel and Widdop, 1978) and has advantages compared with haemodialysis (Vale et al., 1975) . Most experimental work and the subsequent clinical application of haemoperfusion relate to poisoning with one agent, usually a sedative or hypnotic drug Vale et al., 1975) ; as (Fig. 1) .
Haemoperfusion with a 2% acrylic hydrogelcoated charcoal column (Haemocol-100, Smith and Nephew Research Ltd, Harlow, Essex) was commenced and continued for 12 hr, during which time an infusion of colloids maintained the systolic BP above 80 mmHg and allowed further reductions of the dopamine infusion. Heparin was given by infusion to achieve a plasma heparin concentration of 3 u./ml. There were no haemorrhagic complications and at the end of haemoperfusion heparinization was reversed by 100 mg protamine. After 6 hr of haemoperfusion the plasma paracetamol concentration had fallen to 40 mg/l (Fig. 2) (Shubin and Weil, 1965) and it is this disparity between vascular capacity and volume that accounts for the reduction in cardiac output and subsequent hypotension. Treatment should therefore be directed towards restoring an effective plasma volume by the infusion of colloids (Shubin and (Goldberg, 1977) but with the central venous pressure maintained at between 5-10 cm HO2 by the infusion of plasma, inotropic support could be gradually withdrawn without any resultant fall in BP.
The other concern was the probability of the patient developing severe hepatic damage as a consequence of the paracetamol overdose. Not only were the plasma paracetamol concentrations exceedingly high in relation to the time after ingestion (Gazzard et al., 1977) but the pre-perfusion plasma paracetamol half-life of 32 hr indicated a poor prognosis (Prescott et al., 1971) . Furthermore, the patient had been taking butobarbitone as a hypnotic for many years, thereby making herself particularly vulnerable to the hepatotoxic effect of paracetamol (Wright and Prescott, 1973) . Fortunately she emerged with only moderate hepatic damage, as assessed biochemically (Gazzard et al., 1977) . Gazzard et al. (1974) found haemoperfusion to be of little value in the early treatment of paracetamol poisoning, although in this study the use of 10% coated charcoal probably accounted for the small quantities of paracetamol extracted. Specific antidotes however are effective in limiting the degree of hepatic damage (Crome et al., 1976a; Douglas, Hamlyn and James, 1976; Prescott et al., 1977) but are generally accepted as being contra-indicated more than 10 hr following the ingestion of paracetamol (Editorial, 1975; Crome et al., 1976b) . Re- 
